|
|
|
|
5 Days
sidebar My mother-in-law received 5 days of oral levofloxacin (Levaquin) for a urinary tract infection.This was followed by 2 months of C. difficile diarrhea, which was treated with metronidazole (Flagyl) and vancomycin. The diarrhea recurred after...
|
|
|
Clinical Characteristics, Outcomes, and Microbiologic Features Associated with Methicillin-Resistant Staphylococcus aureus Bacteremia in Pediatric Patients Treated with Vancomycin
Welsh KJ et al.A total of 22 pediatric patients with MRSA bacteremia were identified. Eleven cases were considered vancomycin treatment failures. Features significantly associated with vancomycin treatment failure were prematurity and...
|
|
|
Optimer shares buoyed by promising Ph3 C. diff data
Shares of Optimer Pharmaceuticals zoomed up 20 percent after the developer announced another set of promising data from a large, late-stage study of its experimental antibiotic, fidaxomicin.And the San Diego-based developer says it is now ready to assemble...
|
|
|
Reports summarize clostridium therapy study results from I. Lowy and co-researchers
- (NewsRx.com) A new study, 'Treatment with monoclonal antibodies against Clostridium difficile toxins,' is now available (see also Clostridium Therapy).According to recent research from the United States, 'New therapies are needed to manage the increasing...
|
|
|
Adding Rifampicin to Vancomycin May Improve Outcome of MRSA Pneumonia
_ Adding Rifampicin to Vancomycin May Improve Outcome of MRSA Pneumonia.
|
|
|
Adding Rifampicin to Vancomycin May Improve Outcome of MRSA Pneumonia
_ Adding Rifampicin to Vancomycin May Improve Outcome of MRSA Pneumonia.
|
|
|
Ecolab launches EnCompass Environmental Hygiene program to improve patient room hygiene
Ecolab Inc.(NYSE: ECL) today announced the launch of its new EnCompass Environmental Hygiene program, a comprehensive clinical program that helps hospitals improve patient room hygiene and prevent the spread of infections. The program includes cleaning...
|
|
|
Hospitals Report Low Compliance With Antibiotic Prophylaxis Guidelines, Australia
Many hospitals are not complying with national guidelines for antibiotic prophylaxis in cardiac surgery, particularly those regarding the duration of antibiotic administration, according to the results of research published in the Medical Journal of Australia....
|
|
|
Ecolab Introduces New Hospital Program to Improve Hygiene in Patient Rooms
Ecolab Inc.(NYSE: ECL) today announced the launch of its new EnCompass„ Environmental Hygiene program, a comprehensive clinical program that helps hospitals improve patient room hygiene and prevent the spread of infections. The program includes...
|
|
|
Ecolab Introduces New Hospital Program to Improve Hygiene in Patient Rooms
PAUL, Minn.--(BUSINESS WIRE)--Ecolab Inc.(NYSE: ECL) today announced the launch of its new EnCompass Environmental Hygiene program, a comprehensive clinical program that helps hospitals improve patient room hygiene and prevent the spread of infections. The...
|
|
|
Influence of intralumenal and antibiotic-lock of vancomycin on the rate of catheter removal in the patients with permanent hemodialysis catheters
Beigi AA et al.Influence of intralumenal and antibiotic-lock of vancomycin on the rate of catheter removal in the patients with permanent hemodialysis catheters.
|
|
|
Therapeutic Options for [Diabetes-Related] Foot Infections
Journal of the American Podiatric Medical Association (02/01/10) Vol.100, No. 1, P. Nicolau, David Stein, Gary E. Foot infections and their complications are among the most common causes of hospitalization in patients with diabetes. Staphylococcus...
|
|
|
Theravance Announces Receipt of Additional FDA Communication Regarding Telavancin NDA for the Treatment of Nos
- Theravance, Inc.(NASDAQ: THRX) announced today that it has received from the U.S. Food and Drug Administration (FDA) a letter indicating that Theravances response to the November 2009 Complete Response letter for the telavancin New Drug Application (NDA)...
|
|
|
FDA Seeks More Data For Theravance, Inc. (THRX) Drug
- Theravance, Inc.(NASDAQ: THRX) announced today that it has received from the U.S. Food and Drug Administration (FDA) a letter indicating that Theravance's response to the November 2009 Complete Response letter for the telavancin New Drug Application (NDA...
|
|
|
Theravance Announces Receipt of Additional FDA Communication Regarding Telavancin NDA for the Treatment of Nos
SOUTH SAN FRANCISCO, CA -- (MARKET WIRE) -- 01/28/10 -- Theravance, Inc.(NASDAQ: THRX) announced today that it has received from the U.S. Food and Drug Administration (FDA) a letter indicating that Theravance's response to the November 2009 Complete...
|
|
|
Theravance Announces Receipt of Additional FDA Communication Regarding Telavancin NDA for the Treatment of Nos
OUTH SAN FRANCISCO, CAMARKETWIRE Theravance, Inc.announced today that it has received from the U.S. Food and Drug Administration (FDA) a letter indicating that Theravance's response to the November 2009 Complete Response letter for the telavancin New Drug...
|
|
|
Theravance reports new delay in infection drug OK
Theravance Inc.said Thursday regulators are not satisfied with new data on its infection drug candidate Vibativ, and the drug developer indicated further clinical studies might be required to win marketing approval. Approval of Vibativ has been held up for...
|
|
|
Theravance Announces Receipt of Additional FDA Communication Regarding Telavancin NDA for the Treatment of Nosocomial Pneumonia
Companies mentioned in this article: Theravance, Inc.SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 01/28/10 -- Theravance, Inc. (NASDAQ: THRX) announced today that it has received from the U.S. Food and Drug Administration (FDA) a letter indicating that...
|
|
|
Are cefuroxime and vancomycin really safe on the corneal endothelial cells
_ Are cefuroxime and vancomycin really safe on the corneal endothelial cells.
|
|
|
Rare MRSA Strain Raises Alarm
A rare and potentially lethal strain of methicillin-resistant Staphylococcus aureus (MRSA) has raised alarms at one Detroit hospital.Of the 16 patients infected with the USA600 strain over a three-year period, eight died within 30 days. The strain also was...
|
|
|
Researchers use high resolution genome sequencing to track virulent strain of MRSA
An international team of researchers has used high resolution genome sequencing to track a particularly virulent strain of MRSA as it traveled between South America, Europe and Southeast Asia.The findings shed light on how these deadly bacteria are able to...
|
|
|
Evolution And Spread Of Drug-Resistant Bacteria Tracked Across Hospitals And Continents
An international team of researchers has used high resolution genome sequencing to track a particularly virulent strain of MRSA as it traveled between South America, Europe and Southeast Asia.The findings shed light on how these deadly bacteria are able to...
|
|
|
Genetics Used to Track Transmission of MRSA Bacteria
Method could help fight this and other dangerous infections, scientists say THURSDAY, Jan.21 (HealthDay News) -- New technology has made it possible, for the first time, to track the potentially deadly bacteria MRSA around the world or from one person to...
|
|
|
1/24/10 - Cepheid Receives FDA Clearance for First Rapid and Accurate Surveillance Test for vanA -- the Resist
Cepheid Receives FDA Clearance for First Rapid and Accurate Surveillance Test for vanA the Resistance Gene Most Associated with Hospital-Acquired VRE Infections 2010 JAN 24 - (NewsRx.com) Cepheid (NASDAQ:CPHD) announced it has received clearance from the U.S.
|
|
|
Mode of Action of Van-M-02, a Novel Glycopeptide Inhibitor of Peptidoglycan Synthesis, in Vancomycin-Resistant
, Kenji Miura,1 Hidenori Yamashiro,1 Kouichi Uotani,1 Satoshi Kojima,1 Takashi Yutsudo,1 Jun Lu,2, Osamu Yoshida,1 Yoshinori Yamano,1 Hideki Maki,1* and Hirokazu Arimoto3* Discovery Research Laboratories, Shionogi & Co., Ltd., Toyonaka, Osaka, Japan,1...
|
